Equity Details
Price & Market Data
Price: $0.79
Daily Change: +$0.0951 / 12.04%
Daily Range: $0.684 - $0.83
Market Cap: $8,481,163
Daily Volume: 835,502
Performance Metrics
1 Week: 7.78%
1 Month: 14.84%
3 Months: 1.02%
6 Months: -7.28%
1 Year: -25.27%
YTD: 9.12%
About PharmaCyte Biotech, Inc. (PMCB)
Analyze the market position of PharmaCyte Biotech, Inc. (PMCB). With a current price of 0.79, the stock exhibits a +$0.0951 / 12.04% daily trend. A market capitalization of 8,481,163 indicates its scale. Discover its performance over 1-month (14.84%) and 3-month (1.02%) periods.
Company Details
Employees: 2
Sector: Health technology
Industry: Pharmaceuticals: other
Country: United States
Details
PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.